In the latest session, Sarepta Therapeutics Inc (NASDAQ: SRPT) closed at $123.88 down -3.72% from its previous closing price of $128.67. In other words, the price has decreased by -$4.79 from its previous closing price. On the day, 850455 shares were traded.
Ratios:
For a deeper understanding of Sarepta Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.45 and its Current Ratio is at 3.95. In the meantime, Its Debt-to-Equity ratio is 1.63 whereas as Long-Term Debt/Eq ratio is at 1.48.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BMO Capital Markets on January 31, 2024, initiated with a Outperform rating and assigned the stock a target price of $170.
On December 12, 2023, Deutsche Bank started tracking the stock assigning a Buy rating and target price of $109.Deutsche Bank initiated its Buy rating on December 12, 2023, with a $109 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Nov 03 when Barry Richard bought 50,000 shares for $78.81 per share. The transaction valued at 3,940,500 led to the insider holds 140,000 shares of the business.
INGRAM DOUGLAS S bought 25,225 shares of SRPT for $2,001,800 on Nov 03. The President & CEO now owns 390,307 shares after completing the transaction at $79.36 per share. On Aug 14, another insider, Chambers Michael Andrew, who serves as the Director of the company, bought 9,979 shares for $109.47 each. As a result, the insider paid 1,092,429 and bolstered with 246,996 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SRPT now has a Market Capitalization of 12.04B and an Enterprise Value of 11.76B. For the stock, the TTM Price-to-Sale (P/S) ratio is 9.35 while its Price-to-Book (P/B) ratio in mrq is 13.51. Its current Enterprise Value per Revenue stands at 9.46 whereas that against EBITDA is -25.91.
Stock Price History:
Over the past 52 weeks, SRPT has reached a high of $159.89, while it has fallen to a 52-week low of $55.25. The 50-Day Moving Average of the stock is 117.27, while the 200-Day Moving Average is calculated to be 111.91.
Shares Statistics:
For the past three months, SRPT has traded an average of 1.23M shares per day and 1.23M over the past ten days. A total of 93.73M shares are outstanding, with a floating share count of 88.29M. Insiders hold about 5.93% of the company’s shares, while institutions hold 86.17% stake in the company. Shares short for SRPT as of Feb 15, 2024 were 4.81M with a Short Ratio of 3.91, compared to 5.68M on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 5.14% and a Short% of Float of 5.36%.
